Safety, Reactogenicity, and Immunogenicity Study of Heterologous Booster Vaccination of a SARS-CoV-2 Recombinant Protein Nanoparticle Vaccine (GBP510)
Condition(s):COVID-19 (Healthy Volunteers)Last Updated:February 14, 2023Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):COVID-19 (Healthy Volunteers)Last Updated:February 14, 2023Active, not recruiting
Condition(s):Heart Failure With Reduced Ejection Fraction; Acute Heart FailureLast Updated:June 1, 2022Active, not recruiting
Condition(s):Obesity, Morbid; Overnutrition; Nutrition Disorders; Overweight and Obesity; Body Weight ChangesLast Updated:October 8, 2020Unknown status
Condition(s):Stroke; Rehabilitation; NutritionLast Updated:March 7, 2024Completed
Condition(s):Cardiac Arrest, Out-Of-HospitalLast Updated:January 5, 2024Recruiting
Condition(s):Stroke; Disability; Function; Rehabilitation; BurdenLast Updated:July 19, 2021Unknown status
Condition(s):InfluenzaLast Updated:July 3, 2015Completed
Condition(s):Asthma; AgedLast Updated:April 30, 2013Unknown status
Condition(s):AnthraxLast Updated:January 4, 2023Completed
Condition(s):InfluenzaLast Updated:November 21, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.